Literature DB >> 34338230

The lung microbiome: progress and promise.

Samantha A Whiteside, John E McGinniss, Ronald G Collman.   

Abstract

The healthy lung was long thought of as sterile, but recent advances using molecular sequencing approaches have detected bacteria at low levels. Healthy lung bacteria largely reflect communities present in the upper respiratory tract that enter the lung via microaspiration, which is balanced by mechanical and immune clearance and likely involves limited local replication. The nature and dynamics of the lung microbiome, therefore, differ from those of ecological niches with robust self-sustaining microbial communities. Aberrant populations (dysbiosis) have been demonstrated in many pulmonary diseases not traditionally considered microbial in origin, and potential pathways of microbe-host crosstalk are emerging. The question now is whether and how dysbiotic microbiota contribute to initiation or perpetuation of injury. The fungal microbiome and virome are less well studied. This Review highlights features of the lung microbiome, unique considerations in studying it, examples of dysbiosis in selected disease, emerging concepts in lung microbiome-host interactions, and critical areas for investigation.

Entities:  

Mesh:

Year:  2021        PMID: 34338230      PMCID: PMC8321564          DOI: 10.1172/JCI150473

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  158 in total

1.  Multi-omic meta-analysis identifies functional signatures of airway microbiome in chronic obstructive pulmonary disease.

Authors:  Zhang Wang; Yuqiong Yang; Zhengzheng Yan; Haiyue Liu; Boxuan Chen; Zhenyu Liang; Fengyan Wang; Bruce E Miller; Ruth Tal-Singer; Xinzhu Yi; Jintian Li; Martin R Stampfli; Hongwei Zhou; Christopher E Brightling; James R Brown; Martin Wu; Rongchang Chen; Wensheng Shu
Journal:  ISME J       Date:  2020-07-27       Impact factor: 10.302

2.  Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth.

Authors:  Peyman Ghorbani; Prisila Santhakumar; Qingda Hu; Pascal Djiadeu; Thomas M S Wolever; Nades Palaniyar; Hartmut Grasemann
Journal:  Eur Respir J       Date:  2015-05-28       Impact factor: 16.671

Review 3.  Chronic obstructive pulmonary disease.

Authors:  Klaus F Rabe; Henrik Watz
Journal:  Lancet       Date:  2017-05-11       Impact factor: 79.321

4.  Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome.

Authors:  Robert P Dickson; Benjamin H Singer; Michael W Newstead; Nicole R Falkowski; John R Erb-Downward; Theodore J Standiford; Gary B Huffnagle
Journal:  Nat Microbiol       Date:  2016-07-18       Impact factor: 17.745

5.  Disordered microbial communities in the upper respiratory tract of cigarette smokers.

Authors:  Emily S Charlson; Jun Chen; Rebecca Custers-Allen; Kyle Bittinger; Hongzhe Li; Rohini Sinha; Jennifer Hwang; Frederic D Bushman; Ronald G Collman
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

6.  Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals.

Authors:  Christine M Bassis; John R Erb-Downward; Robert P Dickson; Christine M Freeman; Thomas M Schmidt; Vincent B Young; James M Beck; Jeffrey L Curtis; Gary B Huffnagle
Journal:  MBio       Date:  2015-03-03       Impact factor: 7.867

7.  Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung.

Authors:  Leopoldo N Segal; Jose C Clemente; Benjamin G Wu; William R Wikoff; Zhan Gao; Yonghua Li; Jane P Ko; William N Rom; Martin J Blaser; Michael D Weiden
Journal:  Thorax       Date:  2016-08-02       Impact factor: 9.139

8.  The microbiota protects against respiratory infection via GM-CSF signaling.

Authors:  Rebecca L Brown; Richard P Sequeira; Thomas B Clarke
Journal:  Nat Commun       Date:  2017-11-15       Impact factor: 14.919

9.  Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.

Authors:  Alexa A Pragman; Katherine A Knutson; Trevor J Gould; Richard E Isaacson; Cavan S Reilly; Chris H Wendt
Journal:  Respir Res       Date:  2019-06-07

10.  Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease.

Authors:  Micheál Mac Aogáin; Kenny J X Lau; Zhao Cai; Jayanth Kumar Narayana; Rikky W Purbojati; Daniela I Drautz-Moses; Nicolas E Gaultier; Tavleen K Jaggi; Pei Yee Tiew; Thun How Ong; Mariko Siyue Koh; Albert Lim Yick Hou; John A Abisheganaden; Krasimira Tsaneva-Atanasova; Stephan C Schuster; Sanjay H Chotirmall
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

View more
  8 in total

Review 1.  Clinical Aspergillus Signatures in COPD and Bronchiectasis.

Authors:  Pei Yee Tiew; Kai Xian Thng; Sanjay H Chotirmall
Journal:  J Fungi (Basel)       Date:  2022-05-05

2.  Lower airway microbiome of children with recurrent wheezing: a clinical cohort study.

Authors:  Lei Zhang; Tao Ai; Cheng Xie; Wanmin Xia; Ying Zhang; Huling Liao; Liangqin Jia; Yinghong Fan; Jia Xu
Journal:  Transl Pediatr       Date:  2022-05

Review 3.  Leaky Gum: The Revisited Origin of Systemic Diseases.

Authors:  Do-Young Park; Jin Young Park; Dahye Lee; Inseong Hwang; Hye-Sung Kim
Journal:  Cells       Date:  2022-03-23       Impact factor: 6.600

Review 4.  The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives.

Authors:  Juan de Dios Caballero; Rafael Cantón; Manuel Ponce-Alonso; Marta María García-Clemente; Elia Gómez G de la Pedrosa; José Luis López-Campos; Luis Máiz; Rosa Del Campo; Miguel Ángel Martínez-García
Journal:  Microorganisms       Date:  2022-04-13

5.  The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis.

Authors:  Thibaud Alin; Clémence Métayer; Marta Avalos-Fernandez; Rodolphe Thiébaut; Raphaël Enaud; Laurence Delhaes
Journal:  Respir Res       Date:  2022-08-23

Review 6.  Smoking-induced microbial dysbiosis in health and disease.

Authors:  Hagit Shapiro; Kim Goldenberg; Karina Ratiner; Eran Elinav
Journal:  Clin Sci (Lond)       Date:  2022-09-30       Impact factor: 6.876

Review 7.  From the nose to the lungs: the intricate journey of airborne pathogens amid commensal bacteria.

Authors:  Claudio Costantini; Emilia Nunzi; Luigina Romani
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-29       Impact factor: 5.282

Review 8.  Alterations in the respiratory tract microbiome in COVID-19: current observations and potential significance.

Authors:  Carter Merenstein; Frederic D Bushman; Ronald G Collman
Journal:  Microbiome       Date:  2022-10-05       Impact factor: 16.837

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.